In a statement, CVS Chief Executive David Joyner highlighted "a significant and durable recovery" at Aetna, and "strong retention" at CVS Caremark. Last quarter, CVS said that Aetna is exiting the ...

CVS Health topped Wall Street expectations for the second quarter and it's hiking its full-year forecast again, as the health ...

CVS Health Corporation (NYSE: CVS) has released its financial results for the second quarter of 2025, showcasing a robust ...

CVS Health raised its annual profit forecast after beating quarterly estimates on Thursday, as tight oversight of higher ...

CVS Health raised its 2025 forecast based on strength in its pharmacy business and improvements in its insurance unit during ...

Shares of CVS Health jumped in premarket trading Thursday after the pharmacy and healthcare giant posted solid second-quarter ...

The pharmaceutical company's top line grew faster than analysts anticipated for the second quarter due to drug launches and continued demand for its blockbuster medicine Dupixent. The Dutch bank ...

CVS CEO David Joyner pointed to strength in its retail pharmacy and improvement in its insurance unit, Aetna, which is ...

CVS Health (CVS) stock gains as the company beats Q2 2025 forecasts with strong insurance and pharmacy performance, and ...

CVS Health's Aetna insurance business reported a medical loss ratio, or the percentage of premiums spent on medical services, ...

Net income fell 42.3% from the same period a year ago to $1.02 billion, due in part to one-time litigation charges, while adjusted earnings per share, which excludes special items, fell to $1.81 from ...